These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 21194737
1. The incidence of isolated para-aortic nodal metastasis in completely staged endometrial cancer patients. Chiang AJ, Yu KJ, Chao KC, Teng NN. Gynecol Oncol; 2011 Apr; 121(1):122-5. PubMed ID: 21194737 [Abstract] [Full Text] [Related]
2. The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes. Abu-Rustum NR, Gomez JD, Alektiar KM, Soslow RA, Hensley ML, Leitao MM, Gardner GJ, Sonoda Y, Chi DS, Barakat RR. Gynecol Oncol; 2009 Nov; 115(2):236-8. PubMed ID: 19666190 [Abstract] [Full Text] [Related]
4. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy. Nelson G, Randall M, Sutton G, Moore D, Hurteau J, Look K. Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373 [Abstract] [Full Text] [Related]
5. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients. Mariani A, Dowdy SC, Cliby WA, Haddock MG, Keeney GL, Lesnick TG, Podratz KC. Gynecol Oncol; 2006 May; 101(2):200-8. PubMed ID: 16510174 [Abstract] [Full Text] [Related]
6. Ultrastaging of para-aortic lymph nodes in stage IIIC1 endometrial cancer: a preliminary report. Todo Y, Suzuki Y, Azuma M, Hatanaka Y, Konno Y, Watari H, Kato H, Matsuno Y, Yamashiro K, Sakuragi N. Gynecol Oncol; 2012 Dec; 127(3):532-7. PubMed ID: 22940490 [Abstract] [Full Text] [Related]
7. Initial failure site according to primary treatment with or without para-aortic lymphadenectomy in endometrial cancer. Todo Y, Kato H, Minobe S, Okamoto K, Suzuki Y, Sudo S, Takeda M, Watari H, Kaneuchi M, Sakuragi N. Gynecol Oncol; 2011 May 01; 121(2):314-8. PubMed ID: 21315429 [Abstract] [Full Text] [Related]
8. Can we omit para-aorta lymph node dissection in endometrial cancer? Tanaka H, Sato H, Miura H, Sato N, Fujimoto T, Konishi Y, Takahashi O, Tanaka T. Jpn J Clin Oncol; 2006 Sep 01; 36(9):578-81. PubMed ID: 16870694 [Abstract] [Full Text] [Related]
9. What is the incidence of isolated paraaortic nodal recurrence in grade 1 endometrial carcinoma? Abu-Rustum NR, Chi DS, Leitao M, Oke EA, Hensley ML, Alektiar KM, Barakat RR. Gynecol Oncol; 2008 Oct 01; 111(1):46-8. PubMed ID: 18657853 [Abstract] [Full Text] [Related]
10. Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer. Fujimoto T, Nanjyo H, Nakamura A, Yokoyama Y, Takano T, Shoji T, Nakahara K, Yamada H, Mizunuma H, Yaegashi N, Sugiyama T, Kurachi H, Sato A, Tanaka T. Gynecol Oncol; 2007 Nov 01; 107(2):253-9. PubMed ID: 17640720 [Abstract] [Full Text] [Related]
11. Lymph-vascular space invasion as a significant risk factor for isolated para-aortic lymph node metastasis in endometrial cancer: a study of 203 consecutive patients. Chang SJ, Kong TW, Kim WY, Yoo SC, Yoon JH, Chang KH, Ryu HS. Ann Surg Oncol; 2011 Jan 01; 18(1):58-64. PubMed ID: 20607418 [Abstract] [Full Text] [Related]
12. Routes of lymphatic spread: a study of 112 consecutive patients with endometrial cancer. Mariani A, Webb MJ, Keeney GL, Podratz KC. Gynecol Oncol; 2001 Apr 01; 81(1):100-4. PubMed ID: 11277658 [Abstract] [Full Text] [Related]
13. Nodal distribution and its significance in FIGO stage IIIc endometrial cancer. McMeekin DS, Lashbrook D, Gold M, Scribner DR, Kamelle S, Tillmanns TD, Mannel R. Gynecol Oncol; 2001 Aug 01; 82(2):375-9. PubMed ID: 11531298 [Abstract] [Full Text] [Related]
14. Pelvic and para-aortic lymphadenectomy for surgical staging of endometrial cancer: morbidity and mortality. Larson DM, Johnson K, Olson KA. Obstet Gynecol; 1992 Jun 01; 79(6):998-1001. PubMed ID: 1579330 [Abstract] [Full Text] [Related]
15. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N. Gynecol Oncol; 2005 Mar 01; 96(3):651-7. PubMed ID: 15721407 [Abstract] [Full Text] [Related]
17. Incidence of metastasis in circumflex iliac nodes distal to the external iliac nodes in intermediate- and high-risk endometrial cancer. Todo Y, Kato H, Okamoto K, Minobe S, Suzuki Y, Ohba Y, Takeda M, Watari H, Kaneuchi M, Sakuragi N. Gynecol Oncol; 2011 Jul 01; 122(1):55-8. PubMed ID: 21507473 [Abstract] [Full Text] [Related]
18. Endometrial cancer--revisiting the importance of pelvic and para aortic lymph nodes. Aalders JG, Thomas G. Gynecol Oncol; 2007 Jan 01; 104(1):222-31. PubMed ID: 17126892 [Abstract] [Full Text] [Related]
19. Incidence of nodal metastasis and isolated aortic metastases in patients with surgically staged endometrioid endometrial cancer. Sautua RR, Goiri K, Calle MA, Marin IJ, Artola AL. Int J Gynecol Cancer; 2015 Jun 01; 25(5):875-8. PubMed ID: 25774712 [Abstract] [Full Text] [Related]
20. Para-aortic lymphadenectomy improves survival in patients with intermediate to high-risk endometrial carcinoma. Chang SJ, Kim WY, Yoon JH, Yoo SC, Chang KH, Ryu HS. Acta Obstet Gynecol Scand; 2008 Jun 01; 87(12):1361-9. PubMed ID: 18951214 [Abstract] [Full Text] [Related] Page: [Next] [New Search]